newsguy
Joined: 11 Jan 2005 Posts: 104913
|
Posted: Wed May 20, 2009 8:08 am Post subject: Piramal Life starts trial of new diabetes drug (Business St |
|
|
Piramal Life Sciences has commenced phase I trial of a new experimental drug molecule P2202 for diabetes metabolic syndrome in Canada. P2202 is the second compound from Eli Lilly and is part of the collaborative agreement between two companies and is being developed for diabetes metabolic syndrome.
[url=http://us.rd.yahoo.com/dailynews/rss/search/diabetes/SIG=133eo9tsb/*http%3A//www.business-standard.com/india/news/piramal-life-starts-trialnew-diabetes-drug/62357/on]Read more...[/url] |
|